Focus Areas

Realizing the potential of Gene Writing

Curing diseases by writing in the code of life

Our Future

At Tessera, we are advancing our Gene Writing™ technology and proprietary LNP delivery system to alter the human genome and effect precise, durable therapeutic change to cure even the most challenging genetic diseases.

We envision a future where we can treat each disease at its source by designing the optimal Gene Writing system for a given disease and delivering therapeutic instructions to the necessary tissue.

Disease Areas
  • Monogenic diseases
  • Genetic approaches for prevalent diseases
Delivery Method
LNP
Initial Focus Tissues
Liver
HSC
Disease Areas
  • Oncology
  • Autoimmune diseases
Delivery Method
LNP
Initial Focus Tissues
T cells
We are now harnessing the power of Gene Writers to accomplish clinically meaningful tasks and hopefully develop a suite of effective drugs to cure a range of diseases.
David Davidson
Chief Medical and Development Officer
Meet David
Meet the leaders of our Gene Writers
See our Leadership